Anne Lewin
Impact in
- Developmental Neuroscience top 2%
- Neurogenesis and neuroplasticity mechanisms
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Fibroblast Growth Factor Research 3
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Sérgio A. Lira (4 shared papers)Rodrigo Bravo (3 shared papers)Violetta Iotsova (1 shared paper)James Loy (1 shared paper)Yi Yang (1 shared paper)Jorge Caamaño (1 shared paper)Richard J. Smeyne (2 shared papers)Rüdiger Klein (1 shared paper)
- Journals
- Cancer Research (5 papers)Inflammation Research (3 papers)Molecular Cancer Therapeutics (3 papers)The Journal of Experimental Medicine (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Anne Lewin
27 papers receiving 2.8k citations
Anne Lewin's Hit Papers
Peers
Comparison fields: 5 of 108
- Developmental Neuroscience 274
- Cancer Research 567
- Cellular and Molecular Neuroscience 702
- Oncology 822
- Immunology 484
Countries citing papers authored by Anne Lewin
This map shows the geographic impact of Anne Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lewin more than expected).
Fields of papers citing papers by Anne Lewin
This network shows the impact of papers produced by Anne Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lewin. The network helps show where Anne Lewin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Lewin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Osteopetrosis in mice lacking NF-κB1 and NF-κB2 Hit paper breakdown → | 1997 | 847 |
| 2 | Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene Hit paper breakdown → | 1994 | 794 |
| 3 | 1995 | 325 | |
| 4 | 1995 | 172 | |
| 5 | 1994 | 101 | |
| 6 | Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. | 2001 | 89 |
| 7 | 1988 | 77 | |
| 8 | 2015 | 72 | |
| 9 | 1998 | 57 | |
| 10 | 2010 | 53 | |
| 11 | 2007 | 44 | |
| 12 | 2005 | 37 | |
| 13 | 2008 | 37 | |
| 14 | 1991 | 30 | |
| 15 | 2022 | 27 | |
| 16 | 1995 | 26 | |
| 17 | 2009 | 23 | |
| 18 | 2011 | 18 | |
| 19 | 1991 | 17 | |
| 20 | 1997 | 13 |
About Anne Lewin
Anne Lewin is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Cellular and Molecular Neuroscience, having authored 28 papers that have together received 2.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Fibroblast Growth Factor Research (3 papers), NF-κB Signaling Pathways (3 papers), Immune Response and Inflammation (3 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Developmental Neuroscience (274 citations), Cancer Research (567 citations), Cellular and Molecular Neuroscience (702 citations), Oncology (822 citations) and Immunology (484 citations). Anne Lewin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Sérgio A. Lira, Rodrigo Bravo, Violetta Iotsova, James Loy, Yi Yang, Jorge Caamaño, Richard J. Smeyne, Rüdiger Klein, Andreas Schnapp and Linda K. Long. Their work appears in journals such as Cancer Research, Inflammation Research, Molecular Cancer Therapeutics, The Journal of Experimental Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.